| Literature DB >> 35888135 |
Aleksey Larionov1, Valentin Volobaev1, Anton Zverev2,3, Evgeniya Vdovina1, Sebastian Bach1, Ekaterina Schetnikova1, Timofey Leshukov4, Konstantin Legoshchin4, Galina Eremeeva2.
Abstract
Particulate matter (PM) <10 μm in size represents an extremely heterogeneous and variable group of objects that can penetrate the human respiratory tract. The present study aimed to isolate samples of coarse and ultrafine PM at some distance from polluting industries (1-1.5 km from the border of open-cast mines). PM was collected from snow samples which allowed the accumulation of a relatively large amount of ultrafine particles (UFPs) (50-60 mg) from five objects: three open-cast mines, coal power plants, and control territories. The chemical composition of PM was examined using absorption spectroscopy, luminescence spectroscopy, high-performance liquid chromatography, X-ray diffraction (XRD), and X-ray fluorescence (XRF) analyses of solid particle material samples. Toxicity was assessed in human MRC-5 lung fibroblasts after 6 h of in vitro exposure to PM samples. The absorption spectra of all the samples contained a wide non-elementary absorption band with a maximum of 270 nm. This band is usually associated with the absorption of dissolved organic matter (DOM). The X-ray fluorescence spectra of all the studied samples showed intense lines of calcium and potassium and less intense lines of silicon, sulfur, chlorine, and titanium. The proliferation of MRC-5 cells that were exposed to PM0.1 samples was significantly (p < 0.01) lower than that of MRC-5 cells exposed to PM10 at the same concentration, except for PM samples obtained from the control point. PM0.1 samples-even those that were collected from control territories-showed increased genotoxicity (micronucleus, ‱) compared to PM10. The study findings suggest that UFPs deserve special attention as a biological agent, distinct from larger PMs.Entities:
Keywords: MRC-5; PM; PM chemical properties; UFP; air pollution; micronucleus
Year: 2022 PMID: 35888135 PMCID: PMC9323517 DOI: 10.3390/life12071047
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Figure 1Location of sample collecting points.
The coordinates and symbols of PM collection points.
| PM Collecting Point | Coordinates | Symbol |
|---|---|---|
| Near v. Krasnoe | N 54°49.976′ E 85°30.363′ | C |
| Open-pit mine “Bachatskiy” | N 54°21.454′ E 86°07.030′ | B |
| Open-pit mine “Novobachatskiy” | N 54°14.774′ E 86°23.112′ | N |
| Coal-fired power plant “Belovskaya” | N 54°27.165′ E 86°26.880′ | P |
| Open-pit mine “Permyakovsky” | N 54°23.802′ E 86°53.972′ | K |
Phase and elemental composition of suspended particles of different sizes.
| Sample | ||||||
|---|---|---|---|---|---|---|
| C | B | N | K | P | ||
| XRD, Raman spectroscopy | PM10 | Quartz (SiO2) (very weak) | Quartz (SiO2) | NaCl | Quartz (SiO2) | Quartz (SiO2) |
| PM0.1 | Gypsum | Calcite (CaCO3) | Calcite (CaCO3) | Calcite (CaCO3)NaCl | Calcite (CaCO3) | |
| XRF | Joint | K, Ca, Si, S, Cl, Ti | ||||
| PM10 | Cr | Ti, Cr, Cu, Zn, Mn, Pt | Cu (weak) | Ti, Cr | Ti, Cr, Cu (weak) | |
| PM0.1 | Sr (weak), Cu, Zn, Hf | Al, Sr, Mn | Al, Sr, Cu (weak) | Zr | Cu (weak), Rn | |
Note: XRD—X-ray diffraction, XRF—X-ray fluorescence.
PAH content in analyzed water samples with an accuracy index, δ, % (p = 0.95).
| No | PAH | B | P | C | N | K | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| C, mkg/L | ±δ, % | C, mkg/L | ±δ, % | C, mkg/L | ±δ, % | C, mkg/L | ±δ, % | C, mkg/L | ±δ, % | ||
| 1 | Anthracene | 0.16 ± 0.07 | 43 | 0.14 ± 0.06 | 43 | 0.12 ± 0.05 | 43 | 0.32 ± 0.14 | 43 | 0.14 ± 0.06 | 43 |
| 2 | Benz[a]anthracene | 9.40 ± 2.73 | 29 | 5.50 ± 1.60 | 29 | 3.80 ± 1.67 | 44 | 1.20 ± 0.53 | 44 | - | - |
| 3 | Benz[a]pyrene | 0.36 ± 0.15 | 43 | 0.49 ± 0.21 | 43 | 0.23 ± 0.10 | 43 | - | - | - | - |
| 4 | Benz[b]fluoranthene | 5.10 ± 1.53 | 30 | 2.65 ± 1.17 | 44 | 1.90 ± 0.84 | 44 | 0.22 ± 0.10 | 44 | - | - |
| 5 | Benz[k]fluoranthene | 3.65 ± 0.91 | 25 | 2.60 ± 0.65 | 25 | 1.75 ± 0.44 | 25 | - | - | - | - |
| 6 | Biphenyl | 1.34 ± 0.58 | 43 | 0.80 ± 0.34 | 43 | 0.62 ± 0.27 | 43 | 0.24 ± 0.10 | 43 | 0.42 ± 0.18 | 43 |
| 7 | Dibenz[a, h]anthracene | 17.28 ± 7.08 | 41 | 6.05 ± 2.48 | 41 | 10.12 ± 4.15 | 41 | 1.80 ± 0.74 | 41 | - | - |
| 8 | Pyrene | 9.98 ± 2.70 | 27 | 6.29 ± 1.70 | 27 | 4.86 ± 1.99 | 41 | - | - | 0.96 ± 0.39 | 41 |
| 9 | Phenanthrene | 20.37 ± 5.70 | 28 | 1.31 ± 0.54 | 41 | 1.31 ± 0.54 | 41 | 0.18 ± 0.07 | 41 | - | - |
| 10 | Fluorantin | 2.56 ± 1.15 | 45 | 1.77 ± 0.80 | 45 | 1.63 ± 0.73 | 45 | 1.22 ± 0.55 | 45 | - | - |
| 11 | Fluoren | - | - | - | - | 0.51 ± 0.21 | 42 | 0.27 ± 0.11 | 42 | 0.50 ± 0.21 | 42 |
| 12 | Chrysen | 2.63 ± 1.18 | 45 | 1.57 ± 0.71 | 45 | 1.10 ± 0.50 | 45 | 0.13 ± 0.06 | 45 | - | - |
| 13 | 2-methylnaphthalene | - | - | - | - | 1.90 ± 0.78 | 41 | 1.32 ± 0.54 | 41 | 1.67 ± 0.68 | 41 |
| 14 | Acenaften | - | - | - | - | - | - | - | - | 2.63 ± 1.13 | 43 |
| 15 | Benz[g, h, i]perylene | - | - | - | - | - | - | - | - | 2.00 ± 0.88 | 44 |
| 16 | Naphthalene All | - | - | - | - | - | - | - | - | - | - |
| All | 72.83 | 29.17 | 29.85 | 6.9 | 8.32 | ||||||
Viability and RICC of MRC-5 cells that were exposed to PM.
| Sample | RICC | Survival Rate, % | |||
|---|---|---|---|---|---|
| Negative control | 100 | 88.75 ± 3.24 | |||
| Dilution control | 87.9 ± 6.76 | 87.80 ± 5.63 | |||
| Positive control (1 mg/mL) | 26.67 ± 24.55 | 70.9 ± 6.97 | |||
| Sample | Concentration, mg/mL | PM10 | PM0.1 | ||
| RICC | Survival rate, % | RICC | Survival rate, % | ||
| C | 1 | 23 ± 6.81 | 85.33 ± 6.59 | 30.67 ± 25.66 | 76 ± 7.35 |
| 0.5 | 34.17 ± 6.46 | 83.17 ± 4.99 | 54.83 ± 24.24 | 80.17 ± 5.74 | |
| 0.25 | 47.17 ± 27.08 | 86.00 ± 6.1 | 48.16 ± 32.42 | 84.67 ± 6.92 | |
| B | 1 | 32.42 ± 21.16 | 80 ± 9.94 | 7.41 ± 10.64 * | 75 ± 7.12 |
| 0.5 | 32.17 ± 12.37 | 84.83 ± 4.07 | 26.39 ± 13.28 | 84 ± 6.74 | |
| 0.25 | 34.2 ± 3.27 | 84 ± 7.48 | 44.98 ± 38.91 | 86 ± 3.9 | |
| N | 1 | 40.33 ± 3.05 | 85 ± 5 | 22.83 ± 2.4 | 75.17 ± 5.78 |
| 0.5 | 37 ± 16.09 | 86.33 ± 1.15 | 31.28 ± 3.59 | 84.57 ± 2.99 | |
| 0.25 | 56 ± 9.54 | 87.33 ± 3.78 | 39.57 ± 6.5 | 84.57 ± 2.44 | |
| K | 1 | 51.4 ± 12.03 * | 84.8 ± 3.49 | 29.43 ± 9.95 * | 79.14 ± 10.11 |
| 0.5 | 63.4 ± 14.43 | 89.6 ± 2.88 | 41.43 ± 8.69 | 78.71 ± 5.76 | |
| 0.25 | 75 ± 16.67 | 86.8 ± 4.6 | 49.71 ± 13.08 | 81.28 ± 4.07 | |
| P | 1 | 42.83 ± 12.16 | 78.92 ± 3.96 | 32.83 ± 2.23 | 75.5 ± 9.65 |
| 0.5 | 55.73 ± 26.54 | 84.64 ± 6.39 | 52.14 ± 19.85 | 81.28 ± 5.82 | |
| 0.25 | 55.58 ± 32.3 | 87.17 ± 4.49 | 50.67 ± 20.59 | 83.83 ± 3.82 | |
Note: *—Marked differences between high and low concentrations of PM (0.25–1 mg/mL) p < 0.01.
Results of micronuclei test of MRC-5 cells that were exposed to PM.
| Sample | Micronuclei, ‰ | Nuclear Protrusion, ‰ | Nucleoplasmic Bridge, ‰ | |||
|---|---|---|---|---|---|---|
| Negative control | 27.87 ± 13.73 | 15.37 ± 9.44 | 2.87 ± 3.04 | |||
| Dilution control | 28.8 ± 8.43 | 15.7 ± 7.41 | 4.9 ± 4.07 | |||
| Positive control (1 mg/mL) | 147.4 ± 76.1 | 113.2 ± 60.71 | 24.1 ± 12.40 | |||
| PM10 | PM0.1 | PM10 | PM0.1 | PM10 | PM0.1 | |
| C | 26.05 ± 14.09 | 65.17 ± 31.49 | 20.11 ± 15.01 | 42.87 ± 19.22 | 4.83 ± 4.02 | 13.39 ± 10.72 |
| B | 48.29 ± 31.55 | 96.52 ± 40.06 | 34.97 ± 31.1 | 58.18 ± 46.77 | 10.47 ± 9.24 | 20.89 ± 11.41 |
| N | 71.17 ± 28.99 | 68.72 ± 43.74 | 78.89 ± 21.17 | 71.57 ± 43.09 | 17.89 ± 9.65 | 21.82 ± 8.87 |
| K | 48.77 ± 22.76 | 53.83 ± 35.4 | 51.60 ± 25.4 | 67.93 ± 36.72 | 17.15 ± 9.96 | 22.51 ± 17.15 |
| P | 39.34 ± 24.08 | 76.13 ± 24.81 | 44.34 ± 24.37 | 62.34 ± 17.56 | 12.94 ± 8.11 | 22.58 ± 15.81 |